Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
RMD Open|February 9, 2023
Potential impact of autoimmune diseases family history in IgG4-related disease: a retrospective cohort studyRuijie Sun, Zheng Liu, Hui Lu, et al.
Journal of Translational Medicine|September 8, 2022
TSLP promoting B cell proliferation and polarizing follicular helper T cell as a therapeutic target in IgG4-related diseaseHui Lu, Xunyao Wu, Yu Peng, et al.
Clinical Rheumatology|May 30, 2025
Exploring the clinical characteristics and long-term outcome of serologically active clinically quiescent IgG4-related disease: knowledge from a prospective cohortJingna Li, Yuxue Nie, Fei Teng, et al.
Clinical Immunology (Orlando, Fla.)|March 23, 2023
Memory CD4+T cell profile is associated with unfavorable prognosis in IgG4-related disease: Risk stratification by machine-learningYuxue Nie, Zheng Liu, Wei Cao, et al.
Clinical and Experimental Rheumatology|July 30, 2025
Evaluating and predicting disease damage accumulation of IgG4-RD over ten years: utility of the IgG4-related Disease Damage IndexJingna Li, Sicheng Huang, Yifei Wang, et al.
Clinical and Experimental Medicine|June 9, 2025
Elevated eosinophil-to-lymphocyte ratio (ELR) as a predictor of relapse for IgG4-related disease: a retrospective study across a decadeNianyi Zhang, Yu Peng, Rongli Li, et al.
Seminars in Arthritis and Rheumatism|May 11, 2023
The external validation of the 2019 ACR/EULAR classification criteria for IgG4-related disease in a large cohort from ChinaZheng Liu, Yuxue Nie, Yu Peng, et al.
Annals of the Rheumatic Diseases|January 12, 2024
Withdrawal of immunosuppressants and low-dose steroids in patients with stable IgG4-RD (WInS IgG4-RD): an investigator-initiated, multicentre, open-label, randomised controlled trialLinyi Peng, Yuxue Nie, Jiaxin Zhou, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 12, 2026
First-Year IgG Dynamics in IgG4-Related Disease: A Critical Window for Predicting Long-Term OutcomesXin He, Yu Peng, Yuxue Nie, et al.
Clinical and Experimental Medicine|September 26, 2023
B cell repopulation trajectory after rituximab treatment in autoimmune diseases: a longitudinal observational studyYuxue Nie, Jingna Li, Di Wu, et al.
Pageof 3